Drug General Information
Drug ID	D0Y7UJ
Former ID	DNC009142
Drug Name	1-(2-(naphthalen-2-yl)ethyl)piperazine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530012]
Structure		Download 2D MOL 3D MOL
Formula	C16H20N2
Canonical SMILES	C1CN(CCN1)CCC2=CC3=CC=CC=C3C=C2
InChI	1S/C16H20N2/c1-2-4-16-13-14(5-6-15(16)3-1)7-10-18-11-8-17-9-12-18/h1-6,13,17H,7-12H2
InChIKey	MXNHEKIHSVXJPG-UHFFFAOYSA-N
PubChem Compound ID	44592243
Target and Pathway
Target(s)	Sodium-dependent serotonin transporter	Target Info	Inhibitor	[530012]
KEGG Pathway	Serotonergic synapse
NetPath Pathway	TCR Signaling Pathway
PANTHER Pathway	5HT1 type receptor mediated signaling pathway
	5HT2 type receptor mediated signaling pathway
	5HT3 type receptor mediated signaling pathway
	5HT4 type receptor mediated signaling pathway
WikiPathways	Monoamine Transport
	SIDS Susceptibility Pathways
	NRF2 pathway
	Synaptic Vesicle Pathway
	Serotonin Transporter Activity
References
Ref 530012	Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. Epub 2009 Feb 20.Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
Ref 530012	Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. Epub 2009 Feb 20.Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.